- ￥3895.06
- Abd Serotec
- 英国
- MCA1169
- 2025年10月10日
- C, IP, WB
- Mouse
- Human
企业认证
相关产品推荐更多 >
![Noxa antibody [114C307.1]](https://img1.dxycdn.com/2023/0711/451/6106825198874858761-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 形态：
液体
- 保存条件：
4度
- 克隆性：
Monoclonal Antibody
- 标记物：
S/N
- 适应物种：
Human
- 宿主：
Mouse
- 应用范围：
C, IP, WB
- 浓度：
请参考说明书
- 靶点：
PI-3 KINASE p85 SUBUNIT BETA
- 抗体英文名：
MOUSE ANTI PI-3 KINASE p85 SUBUNIT BETA
- 抗体名：
MOUSE ANTI PI-3 KINASE p85 SUBUNIT BETA
- 规格：
2 ml
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Evaluating the Therapeutic Potential of mTOR Inhibitors Using Mouse Genetics
effector of PI3K signaling, one of the most frequently activated pathways in cancer. In cells, mTOR is the catalytic core subunit of two distinct complexes, mTORC1 and mTORC2, which are defined by unique mTOR-interacting proteins and have unique functions
on the PI3K p85 regulatory subunit, or the adaptor proteins IRS1 and IRS2. IRS1 and IRS2 are phosphorylated by the activated receptor, generating docking sites for the SH2 domains of p85 and inducing proper assembly of the signalling complex. These SH2–
on the PI3K p85 regulatory subunit, or the adaptor proteins IRS1 and IRS2. IRS1 and IRS2 are phosphorylated by the activated receptor, generating docking sites for the SH2 domains of p85 and inducing proper assembly of the signalling complex. These SH2–
技术资料暂无技术资料 索取技术资料
